Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Kangmei Zeng"'
Autor:
Jiaxin Cao, Kangmei Zeng, Qun Chen, Ting Yang, Feiteng Lu, Chaozhuo Lin, Jianhua Zhan, Wenjuan Ma, Ting Zhou, Yan Huang, Fan Luo, Hongyun Zhao
Publikováno v:
Cell Death and Disease, Vol 15, Iss 3, Pp 1-15 (2024)
Abstract End-stage nasopharyngeal carcinoma (NPC) has unsatisfactory survival. The limited benefit of chemotherapy and the scarcity of targeted drugs are major challenges in NPC. New approaches to treat late-stage NPC are urgently required. In this s
Externí odkaz:
https://doaj.org/article/199c969377334b599c78050b84ac1bbd
Autor:
Zhonghan Zhang, Jinhui Xue, Yunpeng Yang, Wenfeng Fang, Yan Huang, Shen Zhao, Fan Luo, Jiaxin Cao, Kangmei Zeng, Wenjuan Ma, Jianhua Zhan, Feiteng Lu, Li Zhang, Hongyun Zhao
Publikováno v:
MedComm, Vol 5, Iss 6, Pp n/a-n/a (2024)
Abstract TP53 comutation is related to poor prognosis of non‐small cell lung cancer. However, there is limited study focusing on the structural influence of TP53 mutation on third‐generation epidermal growth factor receptor tyrosine kinase inhibi
Externí odkaz:
https://doaj.org/article/efaaf10675ae4c75be284d3463f942ca
Autor:
Zhonghan Zhang, Fan Luo, Jiaxin Cao, Feiteng Lu, Yang Zhang, Yuxiang Ma, Kangmei Zeng, Li Zhang, Hongyun Zhao
Publikováno v:
Journal of Hematology & Oncology, Vol 14, Iss 1, Pp 1-5 (2021)
Abstract Background The bispecific antibody (bsAbs) research around the world has undergone great changes. We analyzed the global trend of bsAbs research and compared the differences in clinical research of bsAbs between China and worldwide. Methods
Externí odkaz:
https://doaj.org/article/c9e098dc498c46359133868ace0ff0ab
Publikováno v:
Cancer Cell International, Vol 21, Iss 1, Pp 1-16 (2021)
Abstract Background Immunotherapy has shown promising efficacy in patients with nasopharyngeal carcinoma (NPC). Lymphocyte activating 3 gene (LAG-3) represents a significant immune target, however, its relationship with NPC remains unclear. This stud
Externí odkaz:
https://doaj.org/article/084c41865c5f4730ab0448cbb5d490c6
Publikováno v:
Cancer Cell International, Vol 22, Iss 1, Pp 1-1 (2022)
Externí odkaz:
https://doaj.org/article/97de27814bc24df1b9125a416dd031c7
Autor:
Zhonghan Zhang, Kangmei Zeng, Shen Zhao, Yuanyuan Zhao, Xue Hou, Fan Luo, Feiteng Lu, Yaxiong Zhang, Ting Zhou, Yuxiang Ma, Yunpeng Yang, Wenfeng Fang, Yan Huang, Li Zhang, Hongyun Zhao
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 11 (2019)
Background: First-line treatments for nonsmall cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR) mutations have been evaluated in various clinical trials. However, it remains unclear which is the optimal treatment. Methods: A
Externí odkaz:
https://doaj.org/article/2bb31cbace41495eabadfc061cc48030
Autor:
Ting Zhou, Kangmei Zeng, Li Zhang, Zhonghan Zhang, Hongyun Zhao, Jia-Xin Cao, Wen-Juan Ma, Fan Luo, Yunpeng Yang, Feiteng Lu, Yan Huang, Su-Xia Lin
Publikováno v:
Lipids in Health and Disease, Vol 20, Iss 1, Pp 1-14 (2021)
Lipids in Health and Disease
Lipids in Health and Disease
Background Cancer patients often exhibit chemotherapy-associated changes in serum lipid profiles, however, their prognostic value before and after adjuvant chemotherapy on survival among non-small-cell lung cancer (NSCLC) patients is unknown. Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb97c9417db679c6b4d0418fcb9b006b
https://doi.org/10.1186/s12944-021-01538-1
https://doi.org/10.1186/s12944-021-01538-1
Autor:
Ting Zhou, Zeng-Fei Xia, Miao Zhen Qiu, Qiuyun Luo, Zhonghan Zhang, Wentao Pan, Fan Luo, Feiteng Lu, Min Luo, Hongyun Zhao, Li Zhang, Dajun Yang, Jia-Xin Cao, Wen-Juan Ma, Kangmei Zeng, Lin Zhang
Publikováno v:
Cell Death & Disease
Cell Death and Disease, Vol 12, Iss 8, Pp 1-14 (2021)
Cell Death and Disease, Vol 12, Iss 8, Pp 1-14 (2021)
Advanced nasopharyngeal carcinoma (NPC) has a poor prognosis, with an unfavorable response to palliative chemotherapy. Unfortunately, there are few effective therapeutic regimens. Therefore, we require novel treatment strategies with enhanced efficac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb46f46c7a7c2a0a55382f4b868e8ffb
https://doi.org/10.1038/s41419-021-04042-7
https://doi.org/10.1038/s41419-021-04042-7
Autor:
Li Zhang, Feiteng Lu, Yan Huang, Hongyun Zhao, Kangmei Zeng, Jia-Xin Cao, Wen-Juan Ma, Fan Luo
Publikováno v:
Cancer Cell International
Cancer Cell International, Vol 21, Iss 1, Pp 1-16 (2021)
Cancer Cell International, Vol 21, Iss 1, Pp 1-16 (2021)
Background Immunotherapy has shown promising efficacy in patients with nasopharyngeal carcinoma (NPC). Lymphocyte activating 3 gene (LAG-3) represents a significant immune target, however, its relationship with NPC remains unclear. This study aimed t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f3c45ebfe886f9de37cc9558f7a7db5
http://europepmc.org/articles/PMC8403354
http://europepmc.org/articles/PMC8403354
Autor:
Kangmei Zeng, Yang Zhang, Hongyun Zhao, Feiteng Lu, Fan Luo, Li Zhang, Yuxiang Ma, Zhonghan Zhang, Jia-Xin Cao
Publikováno v:
Journal of Hematology & Oncology
Journal of Hematology & Oncology, Vol 14, Iss 1, Pp 1-5 (2021)
Journal of Hematology & Oncology, Vol 14, Iss 1, Pp 1-5 (2021)
Background The bispecific antibody (bsAbs) research around the world has undergone great changes. We analyzed the global trend of bsAbs research and compared the differences in clinical research of bsAbs between China and worldwide. Methods BsAbs res
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12b15e936894a36743af96ad660edfa7
https://pubmed.ncbi.nlm.nih.gov/34399818
https://pubmed.ncbi.nlm.nih.gov/34399818